Drug profile · INN
ly01610 ( irinotecan hydrochloride liposome injection ) with 5-fu（fluorouracil injection）
ly01610 ( irinotecan hydrochloride liposome injection ) with 5-fu（fluorouracil injection） is an FDA-listed pharmaceutical active ingredient.
NMPA: clinical trials
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — ly01610 ( irinotecan hydrochloride liposome injection ) with 5-fu（fluorouracil injection）
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.70
Quick answer
ly01610 ( irinotecan hydrochloride liposome injection ) with 5-fu（fluorouracil injection） is an FDA-listed pharmaceutical active ingredient.
Key facts
INN ly01610 ( irinotecan hydrochloride liposome injection ) with 5-fu（fluorouracil injection）
Approval history
| Authority | Status | Date |
|---|---|---|
| NMPA | clinical trials | — |
Frequently asked questions
What is ly01610 ( irinotecan hydrochloride liposome injection ) with 5-fu（fluorouracil injection）?
ly01610 ( irinotecan hydrochloride liposome injection ) with 5-fu（fluorouracil injection） is an FDA-listed pharmaceutical active ingredient.